Dr. Adam Christopher Deising, DO

Dr. Deising practices at Scripps Green Hospital in La Jolla, California, part of Scripps Health.

Dr. Deising's NPI, 1235285222, was assigned on January 25, 2007. Dr. Deising graduated from Pcom in 2005. Dr. Deising holds California license 20A9780.

Dr. Deising's primary practice is Scripps Green Hospital, at 10666 North Torrey Pines Road, La Jolla, CA 92037 in San Diego County. The practice phone is (858) 554-3600.

Dr. Deising's primary practice is Scripps Green Hospital in La Jolla, California, part of Scripps Health. Dr. Deising is also affiliated with Scripps Memorial Hospital La Jolla. The medical group on file is Scripps Clinic Medical Group. Dmand AI also links Dr. Deising to 2 more hospitals, 1 breast imaging center and 1 urgent care center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Deising practices, 6 sites in all. Vendor and product names are available with a free account.

Hepatology is Dr. Deising's primary specialty in the NPI Registry, under taxonomy code 207RI0008X. Dr. Deising is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Deising's licenses on file in 2 states: California and District of Columbia.

Dmand AI lists acid reflux, cirrhosis of the liver, colonoscopy, fatty liver, gastrointestinal bleeding, hepatitis c and upper GI endoscopy among the conditions Dr. Deising treats.

CMS data shows 1,077 Medicare services from Dr. Deising across 12 procedure codes in 2024, for 295 Medicare patients. Medicare paid $85,181 for them.

CMS counts 295 Medicare patients who saw Dr. Deising in 2024. The largest group is 65 to 74, with 184 patients. 73% of them have high blood pressure, and 64% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Deising's median patient age at 62, with 43% women.

In 2024, Dr. Deising wrote 1,029 Medicare Part D claims for 173 patients. 78% of them were for generic drugs. CMS names the drug for 803 of them, across 22 drugs with 11 or more claims each, at $425,204 in total drug cost. In 2023, CMS named 840 claims across 20 drugs.

Dr. Deising accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Deising as offering telehealth. CMS counts 19 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Deising, more than 49% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Deising in 2020. 2020 was the busiest year, with 2. Dr. Deising's most frequent co-authors are Xia Bi, MD, Catherine Therese Frenette, MD and Mark Simonds Riddle, MD.

CMS Open Payments shows 434 general payments to Dr. Deising from 39 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 74% of the total. Mallinckrodt Hospital Products Inc. paid the most, $41,306.

Dr. Deising serves on Maintenance of Certification Committee; AASLD.

Dr. Deising graduated from Pcom in 2005. Dr. Deising is a member of American Association for the Study of Liver Disease, ACG and AGA.

Dr. Deising is in network with 3 carriers, including Aetna, Blue Cross Blue Shield of Michigan and CMS Medicare. HMO plans come from the most carriers, 2. Check the plan with the practice before a visit.